From: The clinical value and cost-effectiveness of treatments for patients with coronary artery disease
OMT (n = 19,467) | 95% CI | PCI (n = 3205) | 95% CI | CABG (n = 1102) | 95% CI | |
---|---|---|---|---|---|---|
Age, mean | 62.96 | 62.80–63.12 | 58.85 | 58.47–59.23 | 60.84 | 60.30–61.39 |
Male | 13,521 (69%) | 13,294–13,751 | 2,650 (83%) | 2550–2753 | 911 (83%) | 853–972 |
Female | 5,913 (30%) | 5763–6066 | 546 (17%) | 501–594 | 189 (17%) | 163–218 |
Chinese | 13,853 (71%) | 13,623–14,086 | 2005 (63%) | 1918–2095 | 712 (65%) | 661–766 |
Malay | 2,266 (12%) | 2173–2361 | 475 (15%) | 433–520 | 161 (15%) | 137–188 |
Indian | 2,498 (13%) | 2401–2598 | 424 (13%) | 385–466 | 115 (10%) | 95–138 |
Others | 850 (4%) | 794–909 | 301 (9%) | 268–337 | 114 (10%) | 94–137 |
Diag LM | 255 (1%) | 225–288 | 67 (2%) | 52–85 | 22 (2%) | 14–33 |
Diag TVD | 3,780 (19%) | 3660–3902 | 588 (18%) | 438–525 | 480 (44%) | 438–525 |
LM & TVD | 1,935 (10%) | 1850–2023 | 143 (4%) | 431–518 | 473 (43%) | 431–518 |
Diabetes | 8,453 (43%) | 8274–8635 | 1185 (37%) | 1119–1254 | 504 (46%) | 461–550 |
Hypertension | 14,456 (74%) | 14,221–14,694 | 2157 (67%) | 2067–2250 | 838 (76%) | 782–897 |
Dyslipidemia | 15,251 (78%) | 15,010–15,495 | 2430 (76%) | 2334–2529 | 911 (83%) | 853–972 |
LVEF ≤ 40% | 3,290 (17%) | 3179–3404 | 441 (14%) | 401–484 | 215 (20%) | 187–246 |